Speaker illustration

Associate Professor Henry Klar Yaggi

New Haven (United States of America)

Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Sleep Apnoea

Session: Sleep Disordered Breathing and Cardiovascular Disease: from Evidence to Experience

Thumbnail

ESC 365 is supported by

logo Novo Nordisk